SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-020505
Filing Date
2023-05-10
Accepted
2023-05-10 16:07:01
Documents
14
Period of Report
2023-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tcon-20230510.htm   iXBRL 8-K 55370
2 EX-99.1 tcon-ex99_1.htm EX-99 133922
3 GRAPHIC img65184791_0.jpg GRAPHIC 23452
  Complete submission text file 0000950170-23-020505.txt   347190

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tcon-20230510_lab.xml EX-101.LAB 12806
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tcon-20230510_pre.xml EX-101.PRE 9461
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tcon-20230510.xsd EX-101.SCH 2481
8 EXTRACTED XBRL INSTANCE DOCUMENT tcon-20230510_htm.xml XML 4550
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Filer) CIK: 0001394319 (see all company filings)

IRS No.: 342037594 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36818 | Film No.: 23906339
SIC: 2836 Biological Products, (No Diagnostic Substances)